Millennium Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Sell |
|
|||||
|
2025
Q1 | $6.33M | Buy |
|
|||||
|
2024
Q4 | $4.86M | Sell |
|
|||||
|
2024
Q3 | $3.46M | Sell |
|
|||||
|
2024
Q2 | $3.67M | Buy |
|
|||||
|
2024
Q1 | $4.06M | Sell |
|
|||||
|
2023
Q4 | $3.65M | Buy |
|
|||||
|
2023
Q3 | $13.5M | Buy |
|
|||||
|
2023
Q2 | $8.58M | Buy |
|
|||||
|
2023
Q1 | $492K | Sell |
|
|||||
|
2022
Q4 | $3.27M | Buy |
|
|||||
|
2022
Q3 | $3.21M | Buy |
|
|||||
|
2022
Q2 | $2.77M | Buy |
|
|||||
|
2022
Q1 | $969K | Sell |
|
|||||
|
2021
Q4 | $5.13M | Buy |
|
|||||
|
2021
Q3 | $5.78M | Buy |
|
|||||
|
2021
Q2 | $3.52M | Sell |
|
|||||
|
2021
Q1 | $8.65M | Buy |
|
|||||
|
2020
Q4 | $1.35M | Sell |
|
|||||
|
2020
Q3 | $724 | Sell |
|
|||||
|
2020
Q2 | $624K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $533K | Buy |
|
|||||
|
2019
Q3 | $281K | Buy |
|
|||||
|
2019
Q2 | $77K | Buy |
|
|||||
|
2019
Q1 | $125K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.94M | Buy |
|
|||||
|
2017
Q4 | $291K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $409K | Buy |
|
|||||
|
2017
Q1 | $293K | Buy |
|